Advanced search
Publication Cover
Toxicology Communications Volume 7, 2023 - Issue 1
Submit an article Journal homepage
599
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Repeat antivenom administration following crotalidae immune F(ab’)2 antivenom in Agkistrodon species: a case series

Erin Ryana AL Poison Information Center, Children’s of Alabama, Birmingham, AL, USAORCID Iconhttps://orcid.org/0009-0001-4591-8136View further author information
ORCID Icon,
Sukhshant Attia AL Poison Information Center, Children’s of Alabama, Birmingham, AL, USA;b Department of Emergency Medicine, University of Alabama-Birmingham, Birmingham, AL, USAORCID Iconhttps://orcid.org/0000-0001-8403-3771View further author information
ORCID Icon,
Stacy Marshalla AL Poison Information Center, Children’s of Alabama, Birmingham, AL, USA;b Department of Emergency Medicine, University of Alabama-Birmingham, Birmingham, AL, USAORCID Iconhttps://orcid.org/0009-0003-0872-2833View further author information
ORCID Icon,
Jessica Riveraa AL Poison Information Center, Children’s of Alabama, Birmingham, AL, USA;b Department of Emergency Medicine, University of Alabama-Birmingham, Birmingham, AL, USAORCID Iconhttps://orcid.org/0000-0002-3320-307XView further author information
ORCID Icon &
William Rushtona AL Poison Information Center, Children’s of Alabama, Birmingham, AL, USA;b Department of Emergency Medicine, University of Alabama-Birmingham, Birmingham, AL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1812-9104View further author information
ORCID Icon
Article: 2280893 | Received 14 Jul 2023, Accepted 01 Nov 2023, Published online: 02 Dec 2023

References

  • Cocchio C, Johnson J, Clifton S. Review of North American pit viper antivenoms. Am J Health Syst Pharm. 2020;77(3):1–4. doi: 10.1093/ajhp/zxz278.
  • Bush SP, Ruha AM, Seifert SA, et al. Comparison of F(ab’)2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol. 2015;53(1):37–45. doi: 10.3109/15563650.2014.974263.
  • Gerardo CJ, Keyler DE, Rapp-Olson M, et al. Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc Sub-group analysis of a clinical trial comparing F(ab’)2 to Fab antivenom. Clin Toxicol. 2022;60(4):521–523. doi: 10.1080/15563650.2021.1973489.
  • ANAVIP. Package insert. Laboratorios Silanes S.A. de C.V; 2021.
  • Ali AJ, Horwitz DA, Mullins ME. Lack of coagulopathy after copperhead snakebites. Ann Emerg Med. 2015;65(4):404–409. doi: 10.1016/j.annemergmed.2014.08.006.
  • Wills BK, Billet M, Rose SR, et al. Prevalence of hematologic toxicity from copperhead envenomation: an observational study. Clin Toxicol. 2020;58(4):262–265. doi: 10.1080/15563650.2019.1644346.
  • Ramirez-Cueva F, Larsen A, Knowlton E, et al. Predictors of FabAV use in copperhead envenomation. Clin Toxicol. 2022;60(5):609–614. doi: 10.1080/15563650.2021.2018454.
  • Ruha AM, Kleinschmidt KC, Greene S, et al. The epidemiology, clinical course, and management of snakebites in the North American snakebite registry. J Med Toxicol. 2017;13(4):309–320. doi: 10.1007/s13181-017-0633-5.
  • Phase 3 multicenter comparative study to confirm safety and effectiveness of the F(ab)2 Antivenom Anavip. ClinicalTrials.gov identifier: NCT00636116. Updated January 01, 2012. https://clinicaltrials.gov/study/NCT00636116.
  • Wilson BZ, Larsen J, Smelski G, et al. Use of crotalidae equine immune F(ab’)2 antivenom for treatment of an agkistrodon envenomation. Clin Toxicol. 2021;59(11):1023–1026. doi: 10.1080/15563650.2021.1892718.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.